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Title  1 
Barriers and facilitators to type 2 diabetes management in the Caribbean region: a systematic review 2 
protocol 3 
 4 
Review objective 5 
The objective of this systematic review is to summarize the barriers and facilitators to type 2 diabetes 6 
management in the Caribbean region. 7 
 8 
Introduction 9 
Type 2 diabetes mellitus (T2DM) is a chronic metabolic condition where the pancreas is unable to 10 
produce sufficient amounts of insulin or the body is unable to use insulin effectively. As a result, there 11 
are high blood glucose levels in the body. T2DM is a type of diabetes that affects approximately 85% 12 
of people with the disease (diabetes).1 It is usually diagnosed in adults.2  13 
 14 
Global prevalence of T2DM  15 
Globally, around 422 million adults were diagnosed with T2DM in 2014; the number has doubled since 16 
1980.3 As a result of this increasing trend, it is quickly becoming an epidemic in some countries.4 17 
 18 
Risk factors for T2DM 19 
Some commonly known risk factors for T2DM are increasing age, ethnicity (such as South Asian, 20 
Chinese, African-Caribbean or Black African origin), a family history of T2DM, a history of gestational 21 
diabetes in woman, physical inactivity, unhealthy diet, overweight or obesity, dyslipidemia, hypertension 22 
and pre-diabetes.5 Persons are more likely to develop T2DM when more risk factors are present.5,6 23 
 24 
Impact and complications of T2DM 25 
T2DM has a huge disease burden, experienced by the patients and their families/carers as well as by 26 
the country’s economy and healthcare system, especially in poorly developed countries.4 T2DM is 27 
associated with long-term macro- and micro-vascular complications.7 Coronary heart disease, 28 
peripheral arterial disease and stroke are macro-vascular complications. Diabetic retinopathy, diabetic 29 
nephropathy and diabetic neuropathy are micro-vascular complications. T2DM is associated with 30 
reduced quality of life and life expectancy.8 It can reduce life expectancy by five to seven years when 31 
55 years old.2,9,10 Globally, T2DM has caused 4.6 million deaths in 2011.11 32 
 33 
Management of T2DM 34 
People with T2DM can live longer healthier lives if their T2DM is detected early and well managed.12 35 
Management is likely to include interventions which will control their blood glucose levels (through a 36 
combination of healthy diet, physical activity and medication, if necessary); control their blood pressure 37 
and blood lipids; and regularly screen their eyes, kidneys and feet to detect any damage and facilitate 38 
early management, if required.2 39 
 40 
T2DM in the Caribbean region 41 
Of people living with diabetes in the Caribbean region, 95% of them have T2DM.13 The prevalence of 42 
T2DM is approximately 9% and is accountable for around 14% of all deaths in the Caribbean region.14 43 
Majority of T2DM associated morbidity and mortality occurs in the productive age group (18-59 years 44 
old), which affects economic growth, negatively impacting the overall productivity of the Caribbean 45 
region.15 T2DM is, therefore, one of the most significant public health challenges in the Caribbean region 46 
in this twenty-first century.15 47 
 48 
Few studies have been published on the complications of T2DM in the Caribbean region. One study 49 
conducted in Barbados reported that the cumulative incidence of diabetic retinopathy in people with 50 
T2DM was 32% over a four-year period and rose to 40% over a nine-year period.16,17 Another study 51 
conducted among T2DM patients in Trinidad reported that around half of them had symptoms of diabetic 52 
neuropathy, 12% had a history of diabetic foot, and 4% had to undergo amputation.18 In another study 53 
conducted in Barbados, the incidence of lower extremity amputation on diabetic foot was 936 per 54 
100,000 persons.19 55 
 56 
In the 1990s, two studies reported that the overall quality of care of T2DM patients was unsatisfactory 57 
in the Caribbean region and more specifically in Barbados, Trinidad, Tobago, Tortola and Jamaica.20,21 58 
Around 50% of T2DM patients had poor glucose control.20 The care issues reported were inadequate 59 
guidance on diet and physical activity, monitoring of blood glucose levels, and screening for 60 
complications.21  61 
 62 
In the Caribbean region, a guideline is available to manage T2DM at the primary care level.13 This 63 
guideline is for T2DM patients, their families/carers and healthcare professionals whose work involves 64 
the management of T2DM (such as providers and commissioners). This guideline focuses on patient 65 
education, lifestyle advice, managing blood glucose levels, managing cardiovascular risk, and 66 
identifying and managing long-term complications.13  67 
 68 
The rationale for the systematic review 69 
Several studies have been conducted in the Caribbean region on barriers and facilitators to T2DM 70 
management,21-28 which have identified poor access to health care, difficulty in maintaining behaviour 71 
change and negative attitudes about living with T2DM as potential barriers and support from family 72 
members as a potential facilitator.   73 
Until now, no systematic review has been conducted on this topic. Our systematic review aims to 74 
summarize these barriers and facilitators, which can occur at the patient level (including their 75 
family/carer), at the healthcare provider level or at the healthcare commissioner level. By providing a 76 
complete picture of the issue, this systematic review may help the health experts to address the barriers 77 
and promote the facilitators, by taking necessary actions.  78 
 79 
 80 
Keywords 81 
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 83 
Methods  84 
The systematic review process will adhere to the Preferred Reporting Items for Systematic reviews and 85 
Meta-Analyses (PRISMA)29 and the Joanna Briggs Institute (JBI) methodology for qualitative evidence 86 
systematic reviews guidelines.30 87 
 88 
Inclusion criteria 89 
Types of participants  90 
This review will include studies conducted among adults (aged 18 and above) with T2DM, their families/ 91 
carers (a person who looks after a T2DM patient) and healthcare professionals whose work involves 92 
the management of T2DM (such as providers and commissioners).  93 
 94 
Phenomena of interest 95 
This review will include studies that focus on the views, experiences, attitudes, understandings, 96 
perceptions and perspectives regarding the barriers and facilitators to T2DM management. 97 
 98 
Context 99 
The Caribbean region includes Anguilla, Antigua and Barbuda, Aruba, The Bahamas, Barbados, 100 
Bonaire, British Virgin Islands, Cayman Islands, Cuba, Curacao, Dominica, Dominican Republic, 101 
Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Montserrat, Netherlands Antilles, Puerto Rico, Saint 102 
Kitts and Nevis, Saint Barthelemy, Saint Lucia, Saint Vincent and the Grenadines, Sint Maarten/Saint 103 
Martin, Trinidad and Tobago, Turks and Caicos Islands, US Virgin Islands).31 In the Caribbean region, 104 
any study setting will be included such as community, primary care, secondary care and tertiary care. 105 
 106 
Type of studies 107 
This review will include studies that focus on qualitative data, including, but not limited to, designs such 108 
as phenomenology, ethnography, grounded theory and action research. We will also include cross-109 
sectional surveys where free-text relating to the review question is reported within the paper.  110 
 111 
Search strategy 112 
An initial limited search was carried out in MEDLINE and EMBASE databases using the initial keywords, 113 
and the keywords were type 2 diabetes management, barriers, facilitators and Caribbean. The titles 114 
and abstracts of the studies were screened for keywords, and the index terms used to describe the 115 
article were also identified. The search results were inspected to ensure that the relevant articles were 116 
identified. 117 
 118 
We aim to search a wide range of sources, to find both published and unpublished studies. The following 119 
databases will be searched for published studies: MEDLINE (1946-present), EMBASE (1974-present), 120 
CINAHL (1961-present), PsycINFO (1860-present), BNI (1985-present), AMED (1887-present), Web 121 
of Science (1900-present) and Scopus (1960-present). The search strategy, to be used in MEDLINE, 122 
is detailed in Appendix I.  This search strategy will be adopted for other databases, in consultation with 123 
an information specialist/librarian. The search for unpublished studies will include EthOS, OpenGrey, 124 
ProQuest Dissertations and Theses. The reference list of any identified reviews and primary studies 125 
included in the review will be screened for additional studies. We will restrict to the following six official 126 
languages of the Caribbean English, Spanish, French, Dutch, Haitian Creole and Papiamento.31 127 
 128 
Study selection 129 
Following the search, all identified citations will be collated and uploaded into EndNote X8.2,32 a 130 
reference management software, and duplicates will be removed. Titles and abstracts will be screened 131 
for eligibility using the inclusion criteria by two reviewers independently (ALN and KC/JLB). Studies 132 
identified as potentially eligible or those without an abstract will have their full-text retrieved and their 133 
details will be imported into the JBI premier software for systematic review of the literature, a system 134 
for the unified management, assessment and review of information (JBI SUMARI).33 Full-text of the 135 
studies will be assessed against the inclusion criteria by two reviewers independently (ALN and 136 
KC/JLB). Full-text studies that do not meet the inclusion criteria will be excluded, and the reasons for 137 
exclusion will be reported. Any disagreements that arise between the two reviewers will be resolved 138 
through discussion. If consensus is not reached, then a third reviewer (KC/JLB) will be involved. 139 
 140 
Assessment of methodological quality 141 
Included studies will be critically assessed, independently, by two reviewers (ALN and KC/JLB) using 142 
the standardized critical appraisal tools incorporated within JBI SUMARI.33-35 Any disagreements that 143 
arise between the two reviewers will be resolved through discussion. If consensus is not reached, then 144 
a third reviewer (KC/JLB) will be involved. All studies, regardless of the results of their methodological 145 
quality, will undergo data extraction and synthesis (where possible). 146 
 147 
Data extraction 148 
Data will be extracted from papers included in the review using the standardized data extraction tool 149 
incorporated within JBI SUMARI,33-35 independently by two reviewers (ALN and KC/JLB). The data 150 
extracted will include specific details about the study methods (study type, data collection, data 151 
analysis), country, participant (T2DM patients and families/carers, healthcare providers, healthcare 152 
commissioners) characteristics and sample size, context (community, primary care, secondary care, 153 
tertiary care), phenomena of interest and findings. In the case of cross-sectional surveys, free-text 154 
relating to the review question will be extracted as qualitative data. Any disagreements that arise 155 
between the two reviewers will be resolved through discussion. If consensus is not reached, then a third 156 
reviewer (KC/JLB) will be involved. 157 
 158 
Data synthesis 159 
Study findings from all study designs will, where possible, be pooled using JBI SUMARI with the meta-160 
aggregation approach.
33,35,36 This will involve the aggregation or synthesis of findings to generate a set 161 
of statements that represent that aggregation, through assembling the findings and categorizing these 162 
findings on the basis of similarity in meaning. These categories will then be subjected to a synthesis in 163 
order to produce a single comprehensive set of synthesized findings. Where textual pooling is not 164 
possible, the findings will be presented in narrative form.  165 
 166 
Assessing certainty in the findings  167 
The final synthesized findings will be graded according to the ConQual approach for establishing 168 
confidence in the output of research synthesis and presented in a summary of findings table.37 The 169 
table will include the major elements of the review and details how the ConQual score is developed. 170 
The table will include the title, population, phenomena of interest and context for the specific review. 171 
Each synthesized finding from the review will then be presented along with the type of research 172 
informing it, a score for dependability, credibility and the overall ConQual score.  173 
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Appendix I: Search strategy MEDLINE 279 
 280 
1. exp diabetes mellitus, type 2/ 281 
2. exp diabetes complications/ 282 
3. (MODY or NIDDM or T2DM).tw,kf,ot. 283 
4. ((typ? 2 or typ? II or typ?2 or typ?II) adj diabet$).tw,kf,ot. 284 
5. 1 or 2 or 3 or 4 285 
6. (barrier* or impediment* or challenge* or hindrance* or obstacle* or hurdle* or 286 
obstruction* or deterrent* or facilitator*).mp.  287 
7. exp qualitative research/  288 
8. exp interview/  289 
9. exp focus groups/  290 
10. exp cross-sectional studies/  291 
11. exp surveys and questionnaires/  292 
12. (qualitative or interview* or focus group* or cross-sectional or cross sectional or 293 
survey*).mp.  294 
13. 6 or 7 or 8 or 9 or 10 or 11 or 12 295 
14. exp Caribbean Region/  296 
15. exp Trinidad and Tobago/ 297 
16. exp Antigua and Barbuda/ 298 
17. exp Barbados/ 299 
18. exp Martinique/ 300 
19. exp Dominican Republic/  301 
20. exp Haiti/ 302 
21. exp Jamaica/ 303 
22. exp Puerto Rico/ 304 
23. exp Cuba/ 305 
24. exp Bahamas/  306 
25. exp Dominica/ 307 
26. exp Saint Lucia/ 308 
27. exp Grenada/ 309 
28. exp Guadeloupe/ 310 
29. exp Curacao/ 311 
30. exp Aruba/ 312 
31. exp Netherlands Antilles/ 313 
32. exp United States Virgin Islands/ 314 
33. exp British Virgin Islands/ 315 
34. exp Saint Kitts and Nevis/ 316 
35. exp Sint Maarten/ 317 
36. exp West Indies/  318 
37. exp Saint Vincent and the Grenadines/ 319 
38. ((Caribbean) or (Trinidad) or (Tobago) or (Antigua) or (Barbuda) or (Barbados) or (Martinique) 320 
or (Dominican Republic) or (Haiti) or (Hispaniola) or (Jamaica) or (Puerto Rico) or (Cuba) or 321 
(Bahamas) or (Dominica) or (Saint Lucia) or (Grenada) or (Guadeloupe) or (Curacao) or 322 
(Bonaire) or (Aruba) or (Saba) or (Saint Eustatius) or (Virgin Islands) or (Tortola) or (Virgin 323 
Gorda) or (Jost Van Dyke) or (Anegada) or (Saint Croix) or (Saint Thomas) or (Saint John) or 324 
(Saint Kitts) or (Nevis) or (Saint Christopher) or (Sombrero) or (Saint Martin) or (Sint Maarten) 325 
or (West Indies) or (Saint Vincent) or (Grenadines) or (Eastern Caribbean) or (Greater Antilles) 326 
or (Lesser Antilles) or (Leeward Islands) or (Windward Islands) or (Caribbean Islands) or 327 
(Cayman Islands) or (Montserrat) or (Turks and Caicos Islands) or (Anguilla) or (Saint 328 
Barthelemy)).mp.  329 
39. 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 330 
28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 331 
40. 5 and 13 and 39 332 
